Compare $CBIO vs $PBYI | Chartloom

Compare

$CBIO vs $PBYI

Crescent Biopharma Inc · Puma Biotechnology Inc

CBIO

Crescent Biopharma Inc

PBYI

Puma Biotechnology Inc

Compare $CBIO vs $PBYI

Comparing Crescent Biopharma Inc and Puma Biotechnology Inc

CBIOCrescent Biopharma Inc

PBYIPuma Biotechnology Inc

CBIOCrescent Biopharma Inc

Market cap

$532M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

34.6%

52W performance

23.6%

FCF yield

-28.9%

PBYIPuma Biotechnology Inc

Market cap

$524M

P/E (TTM)

20.26x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-2.9%

YTD performance

78.3%

52W performance

96.7%

FCF yield

7.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CBIO

PBYI

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

PBYI

Puma Biotechnology Inc

Market Cap

CBIO$532M

PBYI$524M

Enterprise Value

CBIO$360M

PBYI$487M

Price

CBIO$14.91

PBYI$10.29

P/E Ratio

CBION/A

PBYI20.26x

P/S Ratio

CBIO44.76x

PBYI2.26x

EV/Sales

CBIO30.32x

PBYI2.11x

EV/EBITDA

CBIO0.00x

PBYI10.51x

P/B Ratio

CBIO3.26x

PBYI3.54x

P/FCF Ratio

CBION/A

PBYI12.75x

EV/FCF

CBIO-2.35x

PBYI11.86x

PEG Ratio

CBION/A

PBYIN/A

Forward P/E (NTM)

CBION/A

PBYIN/A

Forward P/S (NTM)

CBION/A

PBYIN/A

Revenue (TTM)

CBIO$12M

PBYI$231M

Revenue Growth (YoY)

CBION/A

PBYI-2.9%

Forward Rev Growth

CBIO-15.7%

PBYI-1.4%

Gross Margin (TTM)

CBIO0.0%

PBYI74.8%

Operating Margin (TTM)

CBIO0.0%

PBYI13.2%

EBITDA Margin (TTM)

CBIO-1355.3%

PBYI17.7%

Net Margin (TTM)

CBIO-1406.4%

PBYI11.6%

FCF Margin (TTM)

CBIO-1292.8%

PBYI17.8%

Net Income (TTM)

CBIO$-167M

PBYI$27M

FCF (TTM)

CBIO$-154M

PBYI$41M

EPS (TTM)

CBIO-$5.47

PBYI$0.51

ROE (TTM)

CBIO-10026.0%

PBYI20.8%

ROA (TTM)

CBIO-8791.0%

PBYI13.3%

ROIC (TTM)

CBIO-10026.0%

PBYI18.4%

Cash

CBIO$172M

PBYI$37M

Debt

CBIO$0

PBYI$0

Net Cash/Debt

CBIO$172M

PBYI$37M

Current Ratio (TTM)

CBIO9.66x

PBYI2.91x

Quick Ratio (TTM)

CBIO9.26x

PBYI2.57x

Debt/Equity (TTM)

CBIO0.00x

PBYI0.17x

Debt/Assets (TTM)

CBIO0.0%

PBYI0.0%

Interest Coverage (TTM)

CBION/A

PBYIN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

PBYI0.00x

Beta

CBIO1.39

PBYI1.36

52W Performance

CBIO23.6%

PBYI96.7%

YTD Performance

CBIO34.6%

PBYI78.3%

% from 52W High

CBIO-45.6%

PBYI-0.8%

% from 52W Low

CBIO71.0%

PBYI124.7%

Asset Turnover (TTM)

CBIO0.05x

PBYI1.15x

FCF Yield (TTM)

CBIO-28.9%

PBYI7.8%

Earnings Yield (TTM)

CBIO-31.4%

PBYI5.1%

Dividend Yield (TTM)

CBION/A

PBYIN/A

Rule of 40

CBIO-1,292.8

PBYI14.9

EV/GP/RG

CBION/A

PBYIN/A

Ticker research

View CBIO research View PBYI research

Metric	CBIO Crescent Biopharma Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$532M	$524M
Enterprise Value	$360M	$487M
Price	$14.91	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	44.76x	2.26x
EV/Sales	30.32x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	3.26x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-2.35x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	-15.7%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-1355.3%	17.7%
Net Margin (TTM)	-1406.4%	11.6%
FCF Margin (TTM)	-1292.8%	17.8%
Net Income (TTM)	$-167M	$27M
FCF (TTM)	$-154M	$41M
EPS (TTM)	-$5.47	$0.51
ROE (TTM)	-10026.0%	20.8%
ROA (TTM)	-8791.0%	13.3%
ROIC (TTM)	-10026.0%	18.4%
Financial Health
Cash	$172M	$37M
Debt	$0	$0
Net Cash/Debt	$172M	$37M
Current Ratio (TTM)	9.66x	2.91x
Quick Ratio (TTM)	9.26x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.36
52W Performance	23.6%	96.7%
YTD Performance	34.6%	78.3%
% from 52W High	-45.6%	-0.8%
% from 52W Low	71.0%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.15x
FCF Yield (TTM)	-28.9%	7.8%
Earnings Yield (TTM)	-31.4%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	14.9
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View PBYI research

Valuation

P/E Ratio

PBYI

20.26x

P/S Ratio

PBYI

2.26x

CBIO

44.76x

EV/FCF

CBIO

-2.35x

PBYI

11.86x

Growth & revenue

Revenue Growth TTM

PBYI

-2.9%

Forward Revenue Growth

PBYI

-1.4%

CBIO

-15.7%

Profitability & performance

Gross Margin

PBYI

74.8%

CBIO

0.0%

ROE

PBYI

20.8%

CBIO

-10026.0%

FCF Yield %

PBYI

7.8%

CBIO

-28.9%

52-Week Performance

PBYI

96.7%

CBIO

23.6%

Detailed metrics comparison

CBIO

Crescent Biopharma Inc

PBYI

Puma Biotechnology Inc

Market Cap

CBIO$532M

PBYI$524M

Enterprise Value

CBIO$360M

PBYI$487M

Price

CBIO$14.91

PBYI$10.29

P/E Ratio

CBION/A

PBYI20.26x

P/S Ratio

CBIO44.76x

PBYI2.26x

EV/Sales

CBIO30.32x

PBYI2.11x

EV/EBITDA

CBIO0.00x

PBYI10.51x

P/B Ratio

CBIO3.26x

PBYI3.54x

P/FCF Ratio

CBION/A

PBYI12.75x

EV/FCF

CBIO-2.35x

PBYI11.86x

PEG Ratio

CBION/A

PBYIN/A

Forward P/E (NTM)

CBION/A

PBYIN/A

Forward P/S (NTM)

CBION/A

PBYIN/A

Revenue (TTM)

CBIO$12M

PBYI$231M

Revenue Growth (YoY)

CBION/A

PBYI-2.9%

Forward Rev Growth

CBIO-15.7%

PBYI-1.4%

Gross Margin (TTM)

CBIO0.0%

PBYI74.8%

Operating Margin (TTM)

CBIO0.0%

PBYI13.2%

EBITDA Margin (TTM)

CBIO-1355.3%

PBYI17.7%

Net Margin (TTM)

CBIO-1406.4%

PBYI11.6%

FCF Margin (TTM)

CBIO-1292.8%

PBYI17.8%

Net Income (TTM)

CBIO$-167M

PBYI$27M

FCF (TTM)

CBIO$-154M

PBYI$41M

EPS (TTM)

CBIO-$5.47

PBYI$0.51

ROE (TTM)

CBIO-10026.0%

PBYI20.8%

ROA (TTM)

CBIO-8791.0%

PBYI13.3%

ROIC (TTM)

CBIO-10026.0%

PBYI18.4%

Cash

CBIO$172M

PBYI$37M

Debt

CBIO$0

PBYI$0

Net Cash/Debt

CBIO$172M

PBYI$37M

Current Ratio (TTM)

CBIO9.66x

PBYI2.91x

Quick Ratio (TTM)

CBIO9.26x

PBYI2.57x

Debt/Equity (TTM)

CBIO0.00x

PBYI0.17x

Debt/Assets (TTM)

CBIO0.0%

PBYI0.0%

Interest Coverage (TTM)

CBION/A

PBYIN/A

Net Debt/EBITDA (TTM)

CBIO0.00x

PBYI0.00x

Beta

CBIO1.39

PBYI1.36

52W Performance

CBIO23.6%

PBYI96.7%

YTD Performance

CBIO34.6%

PBYI78.3%

% from 52W High

CBIO-45.6%

PBYI-0.8%

% from 52W Low

CBIO71.0%

PBYI124.7%

Asset Turnover (TTM)

CBIO0.05x

PBYI1.15x

FCF Yield (TTM)

CBIO-28.9%

PBYI7.8%

Earnings Yield (TTM)

CBIO-31.4%

PBYI5.1%

Dividend Yield (TTM)

CBION/A

PBYIN/A

Rule of 40

CBIO-1,292.8

PBYI14.9

EV/GP/RG

CBION/A

PBYIN/A

Ticker research

View CBIO research View PBYI research

Metric	CBIO Crescent Biopharma Inc	PBYI Puma Biotechnology Inc
Market & Valuation
Market Cap	$532M	$524M
Enterprise Value	$360M	$487M
Price	$14.91	$10.29
P/E Ratio	N/A	20.26x
P/S Ratio	44.76x	2.26x
EV/Sales	30.32x	2.11x
EV/EBITDA	0.00x	10.51x
P/B Ratio	3.26x	3.54x
P/FCF Ratio	N/A	12.75x
EV/FCF	-2.35x	11.86x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$12M	$231M
Revenue Growth (YoY)	N/A	-2.9%
Forward Rev Growth	-15.7%	-1.4%
Profitability
Gross Margin (TTM)	0.0%	74.8%
Operating Margin (TTM)	0.0%	13.2%
EBITDA Margin (TTM)	-1355.3%	17.7%
Net Margin (TTM)	-1406.4%	11.6%
FCF Margin (TTM)	-1292.8%	17.8%
Net Income (TTM)	$-167M	$27M
FCF (TTM)	$-154M	$41M
EPS (TTM)	-$5.47	$0.51
ROE (TTM)	-10026.0%	20.8%
ROA (TTM)	-8791.0%	13.3%
ROIC (TTM)	-10026.0%	18.4%
Financial Health
Cash	$172M	$37M
Debt	$0	$0
Net Cash/Debt	$172M	$37M
Current Ratio (TTM)	9.66x	2.91x
Quick Ratio (TTM)	9.26x	2.57x
Debt/Equity (TTM)	0.00x	0.17x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.39	1.36
52W Performance	23.6%	96.7%
YTD Performance	34.6%	78.3%
% from 52W High	-45.6%	-0.8%
% from 52W Low	71.0%	124.7%
Efficiency & Yields
Asset Turnover (TTM)	0.05x	1.15x
FCF Yield (TTM)	-28.9%	7.8%
Earnings Yield (TTM)	-31.4%	5.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-1,292.8	14.9
EV/GP/RG	N/A	N/A
Ticker research	View CBIO research	View PBYI research